These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2004-001910-15 RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTINATIONAL, MULTI-CENTRE, PHASE IIB/III STUDY OF THE EFFICACY AND SAFETY OF THREE DOSES OF SLIT ADMINISTERED AS TABLETS ONCE DAILY TO PATIENTS SUFFERIN... 2006-03-29 bad-data
Completed, but no date 2004-002350-63 Efficacy and Safety of Sublingual Immunotherapy with Ultra-Rush Titration in Children with Allergic Rhinoconjunctivitis to Tree Pollen, a Multicentre DBPC Trial bad-data
Listed as ongoing, but also has a completion date 2005-002501-23 A randomised, double-blind, placebo-controlled, multi-national, multi-centre, phase III extension study to assess the long term efficacy, safety and carry-over effect of one dose of sublingual immuno... 2006-01-16 bad-data
Not reported 2005-002502-34 A randomised, double-blind, placebo-controlled, multi-national, multi-centre, Phase III paediatric study of the efficacy and safety of one dose of sublingual immunotherapy (SLIT) administered as aller... 2006-01-12 due-trials
Ongoing 2005-003008-12 Prospective trial to evaluate the safety of one cluster regimen in patients with allergic rhinitis/ rhinoconjunctivitis and/or mild or moderate allergic asthma to grass polen, tree pollen or mites.b E... not-yet-due
Listed as ongoing, but also has a completion date 2006-003006-26 A randomised, double-blind, placebo-controlled, multi-national, multi-centre, Phase III paediatric study of the efficacy and safety of 300 IR sublingual immunotherapy (SLIT) administered as allergen-b... 2007-12-09 bad-data
Listed as ongoing, but also has a completion date 2006-003258-98 A randomised, double-blind, placebo-controlled, multi-national, multi-centre, Phase III study to assess the long term efficacy, carry-over effect and safety of two dosing regimens of 300 IR sublingual... 2011-09-07 bad-data
Listed as ongoing, but also has a completion date 2007-001454-77 A randomised, double-blind, placebo-controlled, multi-national Phase II/III study of the safety and efficacy of two doses of sublingual immunotherapy (SLIT) administered as allergen-based tablets once... 2010-02-03 bad-data
Listed as ongoing, but also has a completion date 2007-007869-21 A multi-national, randomised, double-blind, placebo-controlled, Phase II study to assess the efficacy and safety of three doses of sublingual immunotherapy administered as recombinant Bet v 1 tablets ... 2009-06-25 bad-data
Listed as ongoing, but also has a completion date 2008-003906-32 A randomised, double-blind, placebo-controlled, multi national, Phase III study of the efficacy and safety of 300 IR sublingual immunotherapy (SLIT), starting 2 months before the grass pollen season, ... 2009-08-31 bad-data
Listed as ongoing, but also has a completion date 2009-011999-30 A randomised, double-blind, placebo-controlled, multi-national, Phase III trial to assess the efficacy and safety of 300 IR sublingual immunotherapy (SLIT) administered as allergen-based tablets once ... 2011-09-30 bad-data
Ongoing 2009-018155-16 Estudio multicéntrico, aleatorizado, abierto, para evaluar la eficacia del tratamiento con inmunoterapia subcutánea con ácaros (Alustal Rapid) mediante rinometría acústica tras provocación nasal en pa... not-yet-due
No trial status on register 2010-020079-22 Determination of sensitivity and specificity of five solutions of allergen extract (5 grasses, birch, ragweed pollens and Dermatophagoides pteronyssinus and Dermatophagoides farinae mites) for diagnos... bad-data
Not reported 2010-020693-42 A randomised, double-blind, placebo-controlled, multi-national, Phase IIIb study to assess the sustained clinical effect and safety of sublingual immunotherapy administered as birch pollen extract sol... 2012-07-05 due-trials
Listed as ongoing, but also has a completion date 2013-000487-28 A dose ranging study investigating the efficacy and safety of sublingual 2015-06-26 bad-data
Completed, report not yet due 2014-004223-46 A randomized, double-blind, placebo-controlled, multi-center study of the efficacy and safety of STG320 sublingual tablets of house dust mite (HDM) allergen extracts in adults and adolescents with HDM... 2018-06-21 not-yet-due